TARDBP and Alzheimer disease: Overall, these data suggest that APOE4 increases TDP-43 burden and likely increases the risk of TDP-43 pathology in AD by processes linked to Alzheimer type pathology and also processes independent of Aβ, thus contributing to detrimental effects of APOE4 on cognition later in life.